Saturday, December 13, 2025
HomeTagsFDA

Tag: FDA

Automation in AI

Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm

Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling...
Healthcare

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Exo®, a medical imaging software and devices company, announced its FDA-cleared cardiac and lungartificial intelligence (AI) applications are now available on Exo Iris™, Exo’s...
Healthcare

Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection

Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of time Epitel, a leader in AI...
Healthcare

FDA Approves Genentech’s Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer

This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant...
Healthcare

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer’s disease diagnosis

Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is...
Healthcare

Intelligencia AI Awarded U.S. Patent for Its Accurate and Transparent Probability of Drug Success Assessments

Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, announced that the U.S. Patent and Trademark Office (USPTO) issued...
Healthcare

Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive...

Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc., announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn™ (developed as CT-152), the...
1...456...9Page 5 of 9

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2025 AITech365. All Rights Reserved. Website Undertaking: Data Demand